Therapeutics and mild cognitive impairment: current status and future directions

Alzheimer Dis Assoc Disord. 2003 Apr-Jun:17 Suppl 2:S69-71. doi: 10.1097/00002093-200304002-00012.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Alzheimer Disease / pathology
  • Alzheimer Disease / prevention & control
  • Alzheimer Disease / therapy*
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology
  • Cholinergic Antagonists / pharmacology*
  • Cholinesterase Inhibitors / pharmacology
  • Clinical Trials as Topic
  • Donepezil
  • Estrogens / pharmacology
  • Humans
  • Indans / pharmacology
  • Inflammation
  • Piperidines / pharmacology
  • Severity of Illness Index
  • Treatment Outcome
  • Vitamin E / pharmacology

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cholinergic Antagonists
  • Cholinesterase Inhibitors
  • Estrogens
  • Indans
  • Piperidines
  • Vitamin E
  • Donepezil